t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature.

Jad J Wakim, Carlos A Tirado, Weina Chen, Robert Collins

Journal: Leukemia research 2011;35(9):e151-3

PMID: 21628071

Full Text on Elsevier Science View on PubMed

Abstract

DOI: 10.1016/j.leukres.2011.05.013

Link outs

Free resources

Miscellaneous:

https://assays.cancer.gov/CPTAC-1773

Subscription / membership required

Full Text Sources:

MeSH Terms: Antineoplastic Agents, Benzenesulfonates, Chromosomes, Human, Pair 22, Chromosomes, Human, Pair 8, Diagnosis, Differential, Humans, Myeloproliferative Disorders, Niacinamide, Oncogene Proteins, Fusion, Phenylurea Compounds, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Proto-Oncogene Proteins c-bcr, Pyridines, Receptor, Fibroblast Growth Factor, Type 1, Sorafenib, Translocation, Genetic

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.